Close

Your request has been taken into account.

An email has just been sent to you with a link to download the resource :)

🚀 Unlock the power of LCA 2.0: Streamline the evaluation of emissions for several products and smoothly incorporate the data into your GHG reports!

Cytokinetics makes a commitment to the climate and carries out its carbon assessment

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, they are developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

1998

Date of creation

424

Number of employees

2021

Year analyzed

Join over 1500 committed companies for the climate

Ask for a demo